Key points are not available for this paper at this time.
Vandetanib demonstrated therapeutic efficacy in a phase III trial of patients with advanced MTC (ClinicalTrials.gov NCT00410761).
Share your take
Add a clinician perspective alongside expert commentary.
Wells et al. (2011) studied this question.